Variant report
Variant | nsv523840 |
---|---|
Chromosome Location | chr4:62274626-62289032 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs13107100 | chr4:62274626-62274627 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs553545524 | chr4:62274676-62274677 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187721202 | chr4:62274693-62274694 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs191392034 | chr4:62274721-62274722 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550423936 | chr4:62274776-62274777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs554938825 | chr4:62274795-62274796 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs576422163 | chr4:62274809-62274810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543714383 | chr4:62274880-62274881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547091413 | chr4:62274946-62274947 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568535668 | chr4:62274948-62274949 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7660930 | chr4:62274963-62274964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs201419553 | chr4:62274974-62274975 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs187036122 | chr4:62274987-62274988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs35295982 | chr4:62275010-62275011 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs560377062 | chr4:62275043-62275044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs201028487 | chr4:62275079-62275080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112488684 | chr4:62275089-62275090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs33993959 | chr4:62275090-62275091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs549148667 | chr4:62275093-62275094 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557899698 | chr4:62275100-62275101 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs368791418 | chr4:62275121-62275122 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374455280 | chr4:62275122-62275123 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10573056 | chr4:62275123-62275124 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543759291 | chr4:62275124-62275125 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs71830613 | chr4:62275128-62275129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs71211381 | chr4:62275138-62275139 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs561110449 | chr4:62275171-62275172 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs7685384 | chr4:62275178-62275179 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs531902996 | chr4:62275300-62275301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs191930888 | chr4:62275331-62275332 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs367951118 | chr4:62275381-62275382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs6818561 | chr4:62275382-62275383 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs9685219 | chr4:62275391-62275392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs6843523 | chr4:62275398-62275399 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs74703113 | chr4:62275414-62275415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs144274251 | chr4:62275451-62275452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs184407144 | chr4:62275460-62275461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs537354884 | chr4:62275655-62275656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs368428755 | chr4:62275782-62275783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs558567077 | chr4:62275809-62275810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs187650338 | chr4:62275817-62275818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs545049523 | chr4:62275822-62275823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554274322 | chr4:62275879-62275880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs371450810 | chr4:62275891-62275892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs146581021 | chr4:62275937-62275938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs193134066 | chr4:62275989-62275990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs199930135 | chr4:62276013-62276014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs559365408 | chr4:62276076-62276077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547252869 | chr4:62276096-62276097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs561149241 | chr4:62276118-62276119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 20369283 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
Cancer | 20164919 | CNVD |
Lung cancer | 20668451 | CNVD |
Intellectual disability | 21811512 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 22522925 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:62273400-62282600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr4:62273400-62290400 | Weak transcription | Fetal Stomach | stomach |
3 | chr4:62274000-62274800 | Enhancers | NHEK | skin |
4 | chr4:62274000-62275400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr4:62274200-62276400 | Weak transcription | Brain Inferior Temporal Lobe | brain |
6 | chr4:62274200-62277200 | Weak transcription | Fetal Muscle Leg | muscle |
7 | chr4:62274200-62288200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr4:62274600-62274800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr4:62276400-62276600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr4:62276400-62276600 | ZNF genes & repeats | Aorta | Aorta |
11 | chr4:62276400-62276800 | Enhancers | Brain Inferior Temporal Lobe | brain |
12 | chr4:62276600-62276800 | Weak transcription | Aorta | Aorta |
13 | chr4:62282400-62282600 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
14 | chr4:62282600-62283000 | ZNF genes & repeats | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr4:62282600-62283000 | ZNF genes & repeats | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
16 | chr4:62283000-62289400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
17 | chr4:62284200-62289800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
18 | chr4:62285800-62294800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
19 | chr4:62286800-62290400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |